Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Primerica, Inc. (PRI): Dominance For One Financial Firm

Page 1 of 2

Primerica, Inc. (NYSE:PRI) distributes financial products (life insurance, mutual funds, debt elimination) to the underserved middle class in the U.S., Canada, Puerto Rico, and Spain. Yes, the company only has a market cap of $1.8 billion, but recently joined the Standard & Poor’s Mid Cap 400 index. Primerica has partnered with many companies from the time it was founded in 1977, but is its future as bright as its partners/competitors?

Primerica, Inc. (NYSE:PRI)Invesco is a very well-known financial firm that has partnered with Primerica, Inc. (NYSE:PRI) in the past few years. It was very difficult to drive down I-25 without seeing the name attached to the Denver Bronco’s stadium. With revenues increasing eight of the past ten years (down in 2008 and 2009), the company has generated more than $4 billion in the past TTM. With an industry average of 17, Invesco (NYSE:IVZ) currently shows a P/E of 16.8 and a forward P/E of 12.5.  The company has a market cap of approximately $11.8 billion and a Free Cash Flow (FCF) yield of 4.5%. With Earnings Per Share (EPS) rising just five of the past ten years, its earnings yield is 5.9%.

After 110 years, Legg Mason (NYSE:LM) is a pure global asset manager whose vision is to “be a proven leader in global asset management by delivering specialized investment solutions that meet our clients’ objectives and by rewarding our shareholders and employees.” There has been a long relationship between Legg Mason and Primerica. In 2012, Legg Mason generated approximately $2.6 billion in revenue, and they show a market cap of $3.63 billion. EPS have risen six out of the past ten years, but currently shows a .04% earnings yield. The company shows a forward P/E of 9.8 and a FCF yield of 13%.

I know people that work for MetLife (NYSE:MET) , but I am not sold on buying their stock. MetLife has a market cap of over $39 billion and EPS that have risen seven of the past ten years. MetLife has designed products exclusively for Primerica representatives that have been very successful. We have all seen the blimps with snoopy on them, but will popularity lead to success? The company shows a P/E of 14.8 (5 lower than the industry average), and a forward P/E of only 6.8%. After more than doubling revenues in the past decade, the company grossed $68 billion in the past year. MetLife shows a better earnings yield than any of the other companies at 6.8%. Let’s switch to a different type of financial company that deals primarily with insurance.

Prudential is arguably one of the most well-known insurance companies in the world. The company boasts a market cap of over $26 billion, and a P/E of 20.2. Prudential (NYSE:PRU) is not in partnership with America, but is one of its biggest competitors in the life insurance industry. The majority of Prudential’s life insurance is cash value, which is what Primerica makes money on by replacing it with the cheaper term insurance. The company does boast a dividend yield of 3.6%, compared to an industry average of 2.4%. Prudential shows a forward P/E of just 7.4 and an earnings yield of 5%. Eight of the past ten years Prudential has increased its EPS to $7.22. Prudential has been victim to a lot of scrutiny throughout its tenure, even having a book written exposing unethical practices called  Serpent on the Rock .

Primerica is the largest (number of representatives) independent financial services marketing organization in North America. The company has nearly 100,000 life insurance licensed representatives, and have managed to license over 50% of all mutual fund representatives nationwide in the past few years. Let’s look at some metrics of this company and let you decide if it’s worth your investment dollars.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!